NSE · BROOKS
Brooks Laboratories Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,558
of 5,072 stocks
▼ 281W
Peak #2,530 · 21 Sep 2026
A microcap name in Healthcare, Brooks Laboratories Limited trades at an undemanding earnings multiple, generates a high return on equity, and is growing revenue modestly.
Market Cap
173.83 Cr
P/E Ratio
7.07
P/B Ratio
1.42
ROE
20.04%
ROCE
5.26%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 22.96 Cr | 20.21 Cr | 16.57 Cr | 23.45 Cr |
| Net Profit | -1.79 Cr | 1.52 Cr | 5.50 Cr | 7.98 Cr |
| EPS | -0.61 | 0.52 | 1.87 | 2.71 |
| Operating Profit | 1.62 Cr | 70.35 L | 46.41 L | 2.52 Cr |
Shareholding pattern
Promoter
52.62%
Public
47.38%
Mutual fund holdings
₹19.40
Cr total
1
Schemes
1
Fund Houses
₹19.40 Cr
Total Exposure
Quant Mutual Fund₹19.40 Cr (100.0%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 12 Sep 2024 | Other | Annual General Meeting |
| 14 Sep 2023 | Other | Annual General Meeting |
| 28 Jul 2023 | Rights | Rights 1:16 @ Premium Rs 65/- |
| 22 Sep 2022 | Other | Annual General Meeting |
| 21 Sep 2021 | Other | Annual General Meeting |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.